Beiersdorf reported its H1 2026 results on 3 August 2026 and cut full-year guidance. Source: the company's own release at https://www.beiersdorf.com/newsroom/press-information/all-press-releases/2026/08/03-half-year-results-2026, with same-day coverage from the Reuters wire, Business of Fashion and Investing.com.
The headline is that organic sales for the group fell 3.5% in H1, against a 2.1% increase in the same period of 2025, and that full-year guidance moved to a low-single-digit organic decline from a previous expectation of roughly flat. EBIT margin excluding special items came in at 15.5%, down from 16.1%. The company announced an 18-month turnaround plan for NIVEA and an extra 100 million euros of media spend in H2 versus H2 2025.
That is the story most outlets ran. The more useful number is the one underneath it.
NIVEA organic sales fell 6.8%. The Derma division, which includes Eucerin and Aquaphor, grew 7.8%.
Same company. Same half year. Same macro environment, same input costs, same shopper. A 14-point gap in outcome.
What the gap is actually measuring
It is tempting to read this as mass losing to premium, but that is not quite what it is. Eucerin is not a luxury brand and Aquaphor is not expensive. The gap is not about price tier.
It is about why the product is bought.
Eucerin and Aquaphor are bought to solve something. Dry skin that cracks, a barrier that is not holding, an area that needs treating. The purchase is triggered by a problem the shopper can name, and the product either resolves it or does not. When it does, the customer returns without needing to be reminded that the brand exists.
A large part of the NIVEA range is bought because it is what someone uses. It is familiar, it is reasonably priced, it is on the shelf. That is a genuinely valuable position and it has sustained the brand for decades. It is also the position most exposed when shoppers start paying attention to what they are buying and why.
When money gets tighter and the shelf gets more crowded, habit purchases get audited and problem purchases do not.
Why the extra 100 million euros is the interesting decision
Beiersdorf's response includes 100 million euros of additional H2 media spend. That is a rational move for a business of that size defending a brand of that value.
It is also a demonstration of something founders should notice. When a habit-purchase brand loses momentum, the fix is expensive, because you are paying to re-establish a reason to buy that the product does not supply on its own. Problem-solution brands do not usually need that, because the problem does the marketing.
For a brand at £500k-£5m the implication is uncomfortable but clarifying. You do not have 100 million euros. If your range sits mostly in the habit-purchase category and growth stalls, you cannot buy your way out of it the way Beiersdorf can attempt to. Your options are to reposition the products or to change what you sell.
Which means the time to find out where your range sits is now, while the decision is still cheap.
The exercise worth running this week
Take your SKU list and sort it into two columns without being generous to yourself.
Column one: products a customer buys because they have a specific problem they are trying to fix, and they could tell you what it is. Dryness, breakouts, breakage, sensitivity, pigmentation, a scalp condition.
Column two: products a customer buys because it is what they use. Body wash, a general moisturiser, a shampoo that is fine, a hand cream that is nice.
Then pull the last two quarters of growth for each column separately, not for the range as a whole. The aggregate hides exactly the divergence you are looking for, which is why Beiersdorf's group number is less informative than its divisional split.
Most brands doing this find their growth is concentrated in a smaller set of SKUs than they assumed, and that the products they think of as their core are the flat ones.
What to do with the answer
If column one is where your growth is, the decision is about focus. Put range extension, media and retail conversations behind the problem-solving products, even if the habit products carry more revenue today. Growth compounds from the products that have a reason to be repurchased.
If column two is most of your business, the work is repositioning rather than replacement. Almost every habit product can be given a stated problem it solves, but only if the formulation genuinely supports the claim and you can substantiate it. This is a product and evidence project, not a copywriting one. A body lotion becomes a barrier repair product when the formulation and the testing say it is, and not before.
If your range is genuinely all column two and cannot honestly move, that is worth knowing early. It means your growth has to come from distribution and price rather than from pull, and those are different plans with different costs.
The planning assumption to carry into next year
The most common mistake in a founder's forecast is a growth rate borrowed from the category. That assumption has been quietly wrong for a while and Beiersdorf's H1 makes it explicit: the category number is an average of two very different trajectories, and it describes almost nobody.
Plan from your own split instead. Growth is available, in volume, to brands whose products answer a question the customer is actually asking. It is not available on the basis that the market rises and you rise with it.
A 14-point gap inside one company, in one half year, is about as clear a demonstration of that as this industry produces.